HLTH announces final proration factor of 97.513%

By Lisa Kerner

Charlotte, N.C., Dec. 3 - HLTH Corp. said 85,821,641 shares of its common stock were tendered in the offer ended Nov. 25.

Based on final results from American Stock Transfer & Trust Co., the final proration factor for the offer is 97.513%.

HLTH exercised its right to purchase an additional 2% of its outstanding shares and has accepted for purchase 83,699,922 shares at $8.80 per share, for a total cost of $736.6 million, a company news release said.

It was previously reported that HLTH would purchase up to 80 million shares, or 43%, of its common stock at a price of $8.80 per share in the offer that began in late October.

Dealer manager for the offer was Citi, and the information agent was Innisfree M&A Inc.

HLTH is a health care business, technology and information services company based in Elmwood Park, N.J.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.